Investor alert: investigation of alere inc. announced by law offices of howard g. smith

Bensalem, pa.--(business wire)--law offices of howard g. smith announces an investigation on behalf of investors of alere inc. (“alere” or the “company”) (nyse: alr) concerning the company and its officers’ possible violations of federal securities laws. alere provides point-of-care diagnostics and services for infectious disease, cardiometabolic disease, and toxicology in the united states and internationally. on march 15, 2016, alere announced that it had received a grand jury subpoena from the u.s. department of justice (“doj”) concerning potential violations of the u.s. foreign corrupt practices act. the doj is investigating documents related to the company's sales practices in africa, asia and latin america. as a result of the doj subpoena, alere has now said that it does not expect to timely file its annual report for 2015; and its proposed buyout by abbott laboratories has been jeopardized according to numerous media reports. on this news, alere stock has fallen sharply in value over the course of several trading sessions. if you purchased alere securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact howard g. smith, esquire, of law offices of howard g. smith, 3070 bristol pike, suite 112, bensalem, pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com. this press release may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules.
ALR Ratings Summary
ALR Quant Ranking